Crossmark

Preclinical evaluation of [13xLa]La-FAP-2286 as a novel theranostic agent for tumors expressing fibroblast activation protein

Published Online: 2025-03-03

Authors

Shirpour, Ali

Hadadi, Asghar

Zolghadri, Samaneh

Vosoughi, Sara

Rajabifar, Saeed
License Information

Text and Data Mining valid from 2025-03-03

Version of Record valid from 2025-03-03
More Information

Article History

Received: 7 October 2024

Accepted: 24 February 2025

First Online: 3 March 2025

Declarations

:

: The authors declare no competing interests.

Document is current